FS
Fatema Samreen Sadulla Mohammed
About Fatema Samreen Sadulla Mohammed
Data last updated:
Fatema Samreen Sadulla Mohammed is a Director at Dymocare Pharmaceutical Private Limited (since 2023). The company operates in Pharma. Dymocare Pharmaceutical Private Limited reported revenue of ₹66.7 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dymocare Pharmaceutical Private Limited U51909MH2023PTC396681 | Director | 03 Jan 2023 | 2023 | ₹66.7 Lakh (FY 2025) | Active |
Board colleagues of Fatema Samreen Sadulla Mohammed
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aayesha Tarrannum Abdul Jabbar | 09847848 | Dymocare Pharmaceutical Private Limited | Director |
| Shaikh Mushtaq Shaikh Mukhtar | 09847847 | Dymocare Pharmaceutical Private Limited | Director |
| Ubed Ahemad Khan Nisar Ahemad Khan | 11237480 | Dymocare Pharmaceutical Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Fatema Samreen Sadulla Mohammed
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fatema Samreen Sadulla Mohammed
Fatema Samreen Sadulla Mohammed currently holds 1 directorship: Dymocare Pharmaceutical Private Limited (Director, since 03 Jan 2023, revenue ₹66.7 Lakh (FY 2025)).
Fatema Samreen Sadulla Mohammed was first appointed on 03 Jan 2023 as Director at Dymocare Pharmaceutical Private Limited.
The current boards of Fatema Samreen Sadulla Mohammed's companies include Aayesha Tarrannum Abdul Jabbar (Dymocare Pharmaceutical Private Limited), Shaikh Mushtaq Shaikh Mukhtar (Dymocare Pharmaceutical Private Limited), Ubed Ahemad Khan Nisar Ahemad Khan (Dymocare Pharmaceutical Private Limited).